Halozyme Therapeutics (HALO) Q3 2014 Earnings

11AugConfirmed
Q4 2013
Q1 2014
Q2 2014
Q3 2014
-0.22
-0.19
-0.16
-0.13

Details

Expected EPS
-0.16
Actual EPS
-0.13
Surprise EPS
0.03
Surprise Percent
+18.75%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.13 per share for Q3 2014.

0 Comments

Share your thoughts